SUO 2018 Bladder Cancer

Viewing 1-20 of 21 articles

SUO 2018: An Oncolytic Adenovirus, for BCG-unresponsive Non-muscle-invasive Bladder Cancer (NMIBC): 18-month Follow-up from a Multicenter Phase II Trial

SUO 2018: Before and After Clinical CR from NAC

SUO 2018: Phase 2 Study of Pembrolizumab Monotherapy for High-Risk, Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG): Results from Keynote-057

SUO 2018: The Case for Neoadjuvant Immunotherapy

SUO 2018: The Case for Adjuvant Immunotherapy

SUO 2018: Preclinical Models in Bladder Cancer and Translational Research

SUO 2018: Combination Chemotherapy-Immunotherapy for Bladder Cancer

SUO 2018: European Section Oncology-Urology (ESOU) Lecture: Radical Cystectomy in the Octogenarian

SUO 2018: Role of Trimodality and Comparison with Cystectomy in Muscle Invasive Bladder Cancer

SUO 2018: Long-Term IO Alone for Muscle Invasive Bladder Cancer

SUO 2018: POUT Trial - Adjuvant Therapy for Upper Tract Urothelial Carcinoma

SUO 2018: Upper Urinary Tract Transitional Cell Carcinoma: Neoadjuvant Chemotherapy Prior to Nephroureterectomy

SUO 2018: Adding Topical Therapy to Endoscopic Treatment for Upper Tract Urothelial Carcinoma

SUO 2018: Cancer as a Health Shock: Adverse Financial and Employment Outcomes

SUO 2018: The Diagnosis, Management, and Screening of Lynch Syndrome

SUO 2018: Topical Agents for Upper Tract Urothelial Carcinoma - How to Do It?

SUO 2018: TLD-1433 Photodynamic Therapy for BCG-Unresponsive NMIBC - A Phase IB Clinical Study

SUO 2018: Genomics of Upper Tract Disease

SUO 2018: Role of Adjuvant Therapy - POUT Trial

SUO 2018: Neoadjuvant Chemotherapy Prior to Nephroureterectomy

1
2